/PRNewswire/ AI in Drug Discovery Market size is projected to reach USD 4.0 billion by 2027 from USD 0.6 billion in 2022, at a CAGR of 45.7% during the.
Human Longevity, Inc., a startup founded by genomics pioneer J. Craig Venter, plans to join the public markets via a SPAC merger. If the business combination closes, HLI would receive about $345 million for continued commercialization of its platform that uses genomics, AI, and other technologies for early disease detection and other strategies intended to help people live longer.
/PRNewswire/ According to the new market research report "AI in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep.
CHICAGO, June 15, 2022 /PRNewswire/ According to the new market research report "AI in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep Learning)